Trials / Completed
CompletedNCT03586037
Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012
An Open-label, Sequence-randomized, Three-period, Six-sequence, Multiple Dosing Crossover Clinical Trial to Evaluate the Pharmacokinetic Interaction Between AD-2011 and AD-2012 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the Pharmacokinetic Interaction Between AD-2011 and AD-2012 in healthy male volunteers.
Detailed description
To evaluate the pharmacokinetic Interaction, safety and tolerability of the combination compared with the single administration of AD-2011 and AD-2012.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-2011 10/20 mg | AD-2011 10/20 mg tablet |
| DRUG | AD-2012 80mg | AD-2012 80mg tablet |
| DRUG | AD-2011 10/20 mg + AD-2012 80mg | AD-2011 10/20 mg + AD-2012 80mg tablet |
Timeline
- Start date
- 2018-06-12
- Primary completion
- 2018-08-09
- Completion
- 2018-08-20
- First posted
- 2018-07-13
- Last updated
- 2018-10-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03586037. Inclusion in this directory is not an endorsement.